CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR

Overview Fund Activity
Delisted

CNCR was delisted on the 27th of May, 2025.

Back to rankings

28 hedge funds and large institutions have $12.8M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Holders
28
Holders Change
+5
Holders Change %
+21.74%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
10
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$2.42M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$768K
3
WCA
3
Waratah Capital Advisors
Ontario, Canada
$332K
4
PCM
4
Prelude Capital Management
New York
$291K
5
CIA
5
Choate Investment Advisors
Massachusetts
$248K

Top Sellers

1
LPL Financial
1
LPL Financial
California
$1.1M
2
Jane Street
2
Jane Street
New York
$529K
3
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$336K
4
HighTower Advisors
4
HighTower Advisors
Illinois
$0
5
RPG
5
Risk Paradigm Group
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CIBC Private Wealth Group
26
CIBC Private Wealth Group
Georgia
$12K – – –
AG
27
Advisor Group
Arizona
$12K +$7.29K +310 +155%
Fifth Third Bancorp
28
Fifth Third Bancorp
Ohio
$10K – – –
HighTower Advisors
29
HighTower Advisors
Illinois
– -$207K -7,140 Closed
RPG
30
Risk Paradigm Group
Texas
– -$77K -2,650 Closed
IWM
31
IHT Wealth Management
Illinois
– -$21K -750 Closed
1
2